Condition : Lupus Arthritis, Systemic Lupus Erythematosus Interventions : Drug: AMG 557; Drug: Matching Placebo Sponsors : Amgen; Amgen Recruiting - verified August 2013

Subjects in each treatment group will continue to take their concomitant oral weekly dose of methotrexate (MTX) in addition to daily ASP015K or matching placebo, taken orally with food, daily for 12 w...

Subjects in each treatment group will continue to take their concomitant oral weekly dose of methotrexate (MTX) in addition to daily ASP015K or matching placebo, taken orally with food, daily for 12 w...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo Sponsor : Hoffmann-La Roche Active, not recruiting - verif...

Condition : Rheumatoid Arthritis Intervention : Drug: Iguratimod Sponsor : Jiangsu Simcere Pharmaceutical Co., Ltd. Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo Sponsor : Hoffmann-La Roche Active, not recruiting - verif...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting...

Condition : Sjögren's Syndrome Interventions : Biological: Baminercept; Other: Placebo Sponsor : National Institute of Allergy and Infectious Diseases (NIAID) Recruiting - verified February 2014

This will be an open label multicenter study of the safety and efficacy of an active implantable vagal nerve stimulation (VNS) device in patients with rheumatoid arthritis. Patients who complete study...

Condition : Degenerative Joint Disease of Hip and Knee. Interventions : Drug: Placebo; Drug: Gapabentin Sponsor : Rutgers, The State University of New Jersey Recruiting - verified November 2013